Low PRL levels are associated with a higher prevalence of type 2 diabetes (T2D), IR, glucose intolerance, MS, AT dysfunction, ß-cell dysfunction, NAFLD, and cardiovascular events in humans [27,36]. Here, PRL is linked to myeloid sarcoma.